Zampieri to prepare computer science students for artificial intelligence assisted software development
Grant and Award Announcement
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 3-Nov-2026 07:16 ET (3-Nov-2026 12:16 GMT/UTC)
The University of Texas MD Anderson Cancer Center and Springer Nature will co-host a conference to explore the latest research on cancer therapeutics, highlighting advances in the development of next-generation treatment modalities and the technologies enabling them. “Next Generation Cancer Therapeutics” is scheduled for Oct. 6-8, 2026, on the UT MD Anderson campus.
A research paper by scientists at University of Cambridge presented an integrated bone–eye axis framework showing that lower bone mineral density is associated with higher age-related macular degeneration risk and may serve as an accessible marker of systemic aging-related retinal vulnerability.
The research paper, published on Sept 14, 2026 in the journal Cyborg and Bionic Systems.Following the publication of its latest study in Nature Biotechnology, Insilico Medicine founder and CEO Alex Zhavoronkov, Ph.D., took the stage at Sorbonne University during the Nature AI Conference on Redefining Healthcare in the Age of AI to deliver a detailed presentation of the breakthrough findings.
Addressing an audience of global research leaders, clinical investigators, and biopharma innovators, Zhavoronkov detailed how the company’s AI-driven novel drug candidate, rentosertib (ISM001-055), achieved a unanimous reversal of biological age across six independent proteomic aging clocks in a Phase IIa clinical trial.